Cytek Biosciences, Inc. (CTKB)
USD 6.24
(-2.95%)
USD 6.24
(-2.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 193.01 Million | 164.03 Million | 127.95 Million | 92.83 Million | 57.88 Million |
| Cost of Revenue | 83.58 Million | 63.06 Million | 48.8 Million | 41.12 Million | 29.2 Million |
| Gross Profit | 109.42 Million | 100.97 Million | 79.14 Million | 51.71 Million | 28.67 Million |
| Operating Expenses | 137.27 Million | 102.77 Million | 69.97 Million | 38.05 Million | 25.91 Million |
| Selling, General and Administrative Expenses | 91.62 Million | 67.92 Million | 45.53 Million | 24.35 Million | 16.98 Million |
| Research and Development Expenses | 44.15 Million | 34.85 Million | 24.44 Million | 13.69 Million | 8.93 Million |
| Other Expenses | - | 1.01 Million | -1.52 Million | 994 Thousand | 252 Thousand |
| Cost and Expenses | 220.86 Million | 165.84 Million | 118.78 Million | 79.18 Million | 55.12 Million |
| Operating Income | -27.84 Million | -1.82 Million | 6.44 Million | 13.65 Million | 3.72 Million |
| Interest Expense | 2.07 Million | 2.57 Million | 1.74 Million | 333 Thousand | 1000.00 |
| Income Tax Expense | -3.56 Million | -1.22 Million | 1.5 Million | -4.98 Million | 533 Thousand |
| Earnings before Tax | -15.7 Million | 1.26 Million | 5.94 Million | 14.43 Million | -16.29 Million |
| Net Income | -12.14 Million | 2.57 Million | 4.41 Million | 19.41 Million | -16.82 Million |
| Earnings Per Share Basic | -0.09 | 0.02 | 0.03 | 0.02 | -0.13 |
| Earnings Per Share Diluted | -0.09 | 0.02 | 0.03 | 0.02 | -0.13 |
| Weighted Average Shares Outstanding | 135.28 Million | 134.51 Million | 133.74 Million | 132.99 Million | 132.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.28 Million | 138.56 Million | 133.74 Million | 132.99 Million | 132.99 Million |
| Gross Margin | 0.57 | 0.62 | 0.62 | 0.56 | 0.50 |
| EBIT Margin | -0.02 | 0.02 | 0.06 | 0.17 | 0.07 |
| Profit Margin | -0.06 | 0.02 | 0.03 | 0.21 | -0.29 |
| EBITDA | -4.4 Million | 9.53 Million | 10.39 Million | 15.36 Million | -15.98 Million |
| Earnings Before Tax Margin | -0.14 | -0.01 | 0.05 | 0.15 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 51.5 Million | 46.61 Million | 44.86 Million | 193.01 Million | 58.23 Million | 48 Million |
| Cost of Revenue | 22.49 Million | 21.18 Million | 21.84 Million | 83.58 Million | 25.18 Million | 20.82 Million |
| Gross Profit | 29 Million | 25.43 Million | 23.01 Million | 109.42 Million | 33.04 Million | 27.17 Million |
| Operating Expenses | 33.25 Million | 33.96 Million | 33.74 Million | 135.77 Million | 33.18 Million | 33.59 Million |
| Selling, General and Administrative Expenses | 23.37 Million | 23.96 Million | 23.95 Million | - | 22.31 Million | 22.42 Million |
| Research and Development Expenses | 9.88 Million | 10 Million | 9.79 Million | - | 10.86 Million | 11.17 Million |
| Other Expenses | - | 59 Thousand | 823 Thousand | 7.79 Million | 3.19 Million | 1.2 Million |
| Cost and Expenses | 55.74 Million | 55.14 Million | 55.59 Million | 219.36 Million | 58.37 Million | 54.42 Million |
| Operating Income | -4.24 Million | -8.52 Million | -10.73 Million | -26.34 Million | -137 Thousand | -6.42 Million |
| Interest Expense | -119 Thousand | 134 Thousand | 441 Thousand | 2.07 Million | 394 Thousand | 595 Thousand |
| Income Tax Expense | -784 Thousand | 3.24 Million | -2.82 Million | -3.56 Million | -1.39 Million | 2.27 Million |
| Earnings before Tax | 157 Thousand | -7.18 Million | -8.99 Million | -15.7 Million | 4.11 Million | -4.18 Million |
| Net Income | 941 Thousand | -10.43 Million | -6.16 Million | -12.14 Million | 5.5 Million | -6.45 Million |
| Earnings Per Share Basic | 0.01 | -0.08 | -0.05 | - | 0.04 | -0.05 |
| Earnings Per Share Diluted | 0.01 | -0.08 | -0.05 | - | 0.04 | -0.05 |
| Weighted Average Shares Outstanding | 131 Million | 131.44 Million | 130.92 Million | 135.28 Million | 130.71 Million | 136.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 132.78 Million | 131.44 Million | 130.92 Million | 135.28 Million | 130.71 Million | 136.17 Million |
| Gross Margin | 0.56 | 0.55 | 0.51 | 0.57 | 0.57 | 0.57 |
| EBIT Margin | -0.08 | -0.13 | -0.18 | - | 0.04 | -0.07 |
| Profit Margin | 0.02 | -0.22 | -0.14 | -0.06 | 0.09 | -0.13 |
| EBITDA | -4.24 Million | -6.04 Million | -8.27 Million | - | 2.28 Million | -3.59 Million |
| Earnings Before Tax Margin | -0.08 | -0.18 | -0.24 | -0.14 | -0.00 | -0.13 |
KHADIM
SULA
EWTX
ARVSMART
4062
APP